Bill analyzes regional and state trends in the U.S. healthcare industry and is a national expert on health exchanges and Medicare. He authors National MCO Analyzers and Market Overviews in multiple regions as well as U.S. Access and Reimbursement reports focusing on autoimmune drugs and opioids.
Latest news
Clarivate to Report Fourth Quarter and Full Year 2025 Results on February 24, 2026
London, U.K., January 28, 2026 – (PR Newswire) – Clarivate Plc (NYSE: CLVT), a leading global provider of transformative intelligence, today announced it will report its financial results for the fourth…
Clarivate Introduces Nexus, Connecting AI Users to Trusted Academic Resources
Clarivate Nexus integrates academic content and services into the AI tools increasingly used by students and researchers, helping libraries and institutions remain central to trusted scholarship. LONDON, UK — January…